Korea Innovative Pharmaceuticals Consortium Launches Advisory Committee for Global New Drug Development
[Asia Economy Reporter Lee Gwan-joo] The Korea Innovative Medicines Consortium (KIMCo) announced on the 18th that it has launched an advisory committee composed of 10 experts with global new drug development experience and capabilities in research and development (R&D), business development, manufacturing quality control, and regulatory science.
The advisory committee consists of Ko Jong-seong, CEO of Genosco; Kim Gong-sik, lawyer at United One Law Group; Kim So-young, former Asia-Pacific Director at IQVIA; Kim Jong-min, CEO of Hangaram Management Innovation Institute; Kim Hee-kyung, CEO of Kain Science; Moon Han-lim, CEO of Medirama; Park Ki-hwan, professor at KAIST; Yoon Dong-min, CEO of Solarstar Ventures; Lee Hyung-gi, professor at Seoul National University Hospital; and Hwang Man-soon, CEO of Korea Investment Partners.
The advisory committee will review collaborative projects aimed at establishing a joint development and joint investment platform that consolidates the resources and capabilities of the pharmaceutical and bio industries, and provide technical advice on the business strategy and operations of the KIMCo foundation.
Heo Kyung-hwa, CEO of KIMCo, emphasized, "Late-stage clinical trials necessary for successful global innovative drug development require enormous capital, and domestic pharmaceutical and bio companies currently have weak development momentum. Through the newly launched advisory committee, we will accelerate the establishment of a joint development and joint investment platform that consolidates expertise in global new drug development."
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Won Hee-mok, chairman of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association, stated, "For Korea to leap forward as a global pharmaceutical and bio powerhouse, continuous innovation in the pharmaceutical and bio industry and global new drug development must be achieved. The advisory committee will play a role in supporting the embedding of global open innovation strategies within the domestic pharmaceutical and bio industry ecosystem."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
